drugset / Trial / NCT02223351
Drug-Drug Interaction Study: ASP2151 and Ritonavir
RandomizedCrossoverOpen-labelOther
Summary
ASP2151 is an experimental treatment for herpes. HIV infected people are susceptible to contracting other infections because of their compromised immune system. As HIV patients will be taking drugs to treat the virus this study aims to see if ASP2151 would interact with one of the drugs that is commonly prescribed to HIV patients (ritonavir).
Timeline
- Start
- 2014-09
- Primary completion
- 2014-12
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amenamevir | Small molecule | 400 mg | — |
| Subject | Amenamevir | Small molecule | 1200 mg | — |
| Subject | Ritonavir | Other / unclassified | 600 mg | Oral |
Indications
No indication recorded.